Eyenovia Inc
NASDAQ:EYEN
Eyenovia Inc
Net Issuance of Debt
Eyenovia Inc
Net Issuance of Debt Peer Comparison
Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Eyenovia Inc
NASDAQ:EYEN
|
Net Issuance of Debt
$4.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Net Issuance of Debt
-$11.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-35%
|
CAGR 10-Years
N/A
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Net Issuance of Debt
$17.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pfizer Inc
NYSE:PFE
|
Net Issuance of Debt
$33.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
50%
|
CAGR 10-Years
67%
|
|
Merck & Co Inc
NYSE:MRK
|
Net Issuance of Debt
$3.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-7%
|
|
Eli Lilly and Co
NYSE:LLY
|
Net Issuance of Debt
$7.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
See Also
What is Eyenovia Inc's Net Issuance of Debt?
Net Issuance of Debt
4.4m
USD
Based on the financial report for Mar 31, 2024, Eyenovia Inc's Net Issuance of Debt amounts to 4.4m USD.
What is Eyenovia Inc's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 1Y
142%
Over the last year, the Net Issuance of Debt growth was 142%.